What is Hangzhou Tigermed Consulting Co OCF Yield %?
Hangzhou Tigermed Consulting CoFRA:5HZ1 +4.62%87 OCF Yield % is 3.26 as of Jul. 07, 2026, which is 92% above its 10-year median of 1.70. GuruFocus rates FRA:5HZ1 with a GF Score™ of 87/100 and a GF Value™ of €5.49 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Hangzhou Tigermed Consulting Co ranks better than 60.93% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Hangzhou Tigermed Consulting Co's OCF Yield % or its related term are showing as below:
FRA:5HZ1'
s OCF Yield % Range Over the Past 10 Years
Min: 0.51 Med: 1.7 Max: 3.89
Current: 3.26
During the past 13 years, the highest OCF Yield % of Hangzhou Tigermed Consulting Co was 3.89%. The lowest was 0.51%. And the median was 1.70%.
FRA:5HZ1's OCF Yield % is ranked better than 60.93% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.05
vs FRA:5HZ1: 3.26
Hangzhou Tigermed Consulting Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Hangzhou Tigermed Consulting Co OCF Yield % Related Terms
Hangzhou Tigermed Consulting Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5HZ1 vs TMO, DHR, IDXX: OCF Yield % Comparison
For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Tigermed Consulting Co OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Hangzhou Tigermed Consulting Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Tigermed Consulting Co (FRA:5HZ1) has a OCF Yield % of 3.26 as of Jul. 07, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hangzhou Tigermed Consulting Co and its competitors. This is 92% above median its historical median of 1.70. Over the past decade, Hangzhou Tigermed Consulting Co's OCF Yield % has ranged from 0.51 to 3.89. According to the industry distribution chart, Hangzhou Tigermed Consulting Co ranks #84 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 39.1%.
Is Hangzhou Tigermed Consulting Co's OCF Yield % too high?
Hangzhou Tigermed Consulting Co's current OCF Yield % of 3.26 is 92% above median its 10-year median of 1.70. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 3.89. The Medical Diagnostics & Research industry median OCF Yield % is 1.05. Hangzhou Tigermed Consulting Co's value of 3.26 is 210.5% above this industry median. Based on the distribution chart, Hangzhou Tigermed Consulting Co ranks #84 out of 215 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Hangzhou Tigermed Consulting Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Tigermed Consulting Co's OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Hangzhou Tigermed Consulting Co ranks #84 out of 215 companies for OCF Yield %. This puts Hangzhou Tigermed Consulting Co in the upper half of its industry. The industry median OCF Yield % is 1.05. Hangzhou Tigermed Consulting Co's value of 3.26 is 210.5% above this benchmark. Historically, Hangzhou Tigermed Consulting Co's own OCF Yield % has ranged from 0.51 to 3.89 over the past decade. While the company's 10-year median is 1.70 vs. the industry median of 1.05, Hangzhou Tigermed Consulting Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.05, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou Tigermed Consulting Co's current OCF Yield % of 3.26 is 210.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hangzhou Tigermed Consulting Co and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou Tigermed Consulting Co's current OCF Yield % is 3.26, which is 92% above median its own 10-year median of 1.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Tigermed Consulting Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co (FRA:5HZ1) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.49, compared to a current price of €4.08 — trading 25.7% below its estimated fair value. The current OCF Yield % is 3.26, which is 92% above median its 10-year median of 1.70 and 210.5% above the Medical Diagnostics & Research industry median of 1.05. Hangzhou Tigermed Consulting Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Hangzhou Tigermed Consulting Co (FRA:5HZ1), the current OCF Yield % is 3.26 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou Tigermed Consulting Co (FRA:5HZ1) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co stock appears to be undervalued.
The current stock price of €4.08 is trading 25.7% below its estimated GF Value™ of €5.49.
GuruFocus considers Hangzhou Tigermed Consulting Co to be Modestly Undervalued.
Key valuation signals for FRA:5HZ1:
OCF Yield %: 3.26 (92% above median its 10-year median of 1.70)
GF Value™: €5.49 vs. price of €4.08 (25.7% below fair value)
Industry Position: 210.5% above the Medical Diagnostics & Research median (#84 of 215)
No single metric tells the full story. See the FRA:5HZ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hangzhou Tigermed Consulting Co Business Description
Hangzhou Tigermed Consulting Co Ltd is a China-based provider of comprehensive biopharmaceutical R&D services, with an expanding world-wide presence. The Group is principally engaged in CRO services.
87GF Score
Get the complete analysis for FRA:5HZ1
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5HZ1 has been successfully added to your 
